# SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)

> **NCT01349894** · — · WITHDRAWN · sponsor: **Solventum US LLC**

## Conditions studied

- Split Thickness Skin Graft
- Skin Cancer Excision Site
- Skin Graft

## Interventions

- **DEVICE:** SNaP® Wound Care System

## Key facts

- **NCT ID:** NCT01349894
- **Lead sponsor:** Solventum US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful.
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349894, "SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01349894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*